Evidence map›Paper›PMID 34353913›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

A

Darshan N Kasal, Zhitao Liang, Maile K Hollinger, Crystal Y O'Leary, Wioletta Lisicka, Anne I Sperling, Albert Bendelac

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. NMolecular medicine (Cambridge, Mass.) · 2024
    Review
  13. Article
  14. A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Review
  16. Cooperation of ILC2s and TNature reviews. Immunology · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Darshan N KasalCommittee on Immunology, University of Chicago, Chicago, IL 60637.ORCID 0000-0003-2718-7971
Zhitao LiangCommittee on Immunology, University of Chicago, Chicago, IL 60637.
Maile K HollingerCommittee on Immunology, University of Chicago, Chicago, IL 60637.ORCID 0000-0001-8303-6188
Crystal Y O'LearyDepartment of Pathology, University of Chicago, Chicago, IL 60637.ORCID 0000-0001-8802-6683
Wioletta LisickaCommittee on Immunology, University of Chicago, Chicago, IL 60637.ORCID 0000-0003-2623-5185
Anne I SperlingCommittee on Immunology, University of Chicago, Chicago, IL 60637.
Albert BendelacCommittee on Immunology, University of Chicago, Chicago, IL 60637; abendela@bsd.uchicago.edu.ORCID 0000-0003-1859-206X
University of Chicago · US

Funding

INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Transcriptional Regulation of Innate-Like T CellsR37AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2017 to 2023
$3.4M
Development of Intestinal Polyreactive IgA B CellsR01AI144094 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2019 to 2023
$2.5M
Specificity of Intestinal Immunoglobulin AU01AI125250 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2016 to 2020
$2.5M
Novel antiviral activity of interferon-gamma against viral replication complexR01AI127518 · NIAID · UNIVERSITY OF CHICAGO · PI RANDALL, GLENN C · 2017 to 2020
$1.6M
NIAID NIH HHS R01 AI127518NIAID NIH HHS R01 AI144094NIAID NIH HHS R37 AI038339NIAID NIH HHS T32 AI007090NIAID NIH HHS U01 AI125250NIGMS NIH HHS R25 GM109439
6 · The paper itself

Abstract

The type 2 helper effector program is driven by the master transcription factor GATA3 and can be expressed by subsets of both innate lymphoid cells (ILCs) and adaptive CD4

Indexed as

Enhancer Elements, GeneticAnimalsCell DifferentiationFemaleGATA3 Transcription FactorHomeostasisImmunity, InnateInflammationLymphocytesMaleMiceMice, Inbred C57BLMice, TransgenicStrongyloidiasisTh2 CellsGata3 protein, mouseGATA3 Transcription FactorGATA3ILC2innate lymphoid cellTh2 celltype 2 immunity

Identifiers

PMID34353913
PMCPMC8364216
OpenAlexW3191478634

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.